Crossmark

Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement

Published Online: 2022-02-16

Published Print: 2022-05

Authors

Kaurinovic, Martina https://orcid.org/0000-0001-6424-2955
Delli, Konstantina https://orcid.org/0000-0003-3115-3977
Jonk, Ana-Mae E.

Biswana, Anouschka

Hazenberg, Carin L. E.

Choi, Goda

de Groot, Marco R.

Morsink, Linde M.

Vissink, Arjan https://orcid.org/0000-0003-2581-4361
Bellido, Mar https://orcid.org/0000-0001-9864-5816
License Information

Text and Data Mining valid from 2022-02-16

Version of Record valid from 2022-02-16
More Information

Article History

Received: 21 November 2021

Accepted: 11 January 2022

First Online: 16 February 2022

Declarations

:

: This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the Medical Ethics Review Board of the University Medical Centre Groningen (No. M19.232532). Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current